Skip to main content
Figure 1 | Annals of Clinical Microbiology and Antimicrobials

Figure 1

From: Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model

Figure 1

A novel in vitro biofilm device integrated in a pharmacokinetic biofilm model system. The device was configured to simulate the in vivo condition in which the biofilms of C. albican on IV vascular catheter are under continuously perfusion with fresh medium and exposed to exponentially decreasing concentrations of antifungal agents.

Back to article page